Abstract
Background
Both myeloperoxidase-associated antineutrophil cytoplasmic antibody (MPO-ANCA) and antiglomerular basement membrane antibody (anti-GBM Ab) positivity have been demonstrated in patients with rapidly progressive glomerulonephritis (RPGN), either with or without pulmonary hemorrhage; however, the implications of these antibodies in such patients have not yet been elucidated. The cases with dual positive antibodies were studied clinically, serologically, and pathologically, and the implications of antibodies are discussed here.
Patients and methods
Four patients with prior pulmonary fibrosis, who subsequently developed RPGN and pulmonary hemorrhage, were studied clinically, serologically, and pathologically. The clinical data were reviewed extensively and the dual positive antibodies were detected by enzyme-linked immunosorbent assays. Pathological studies were performed with a renal biopsy in one patient, a gastric biopsy in another patient, and autopsy materials in the remaining 2 patients.
Results
All 4 patients had prior pulmonary fibrosis before the symptoms of RPGN when the dual positivity of MPO-ANCA and anti-GBM Ab was detected. Three cases were accompanied by pulmonary hemorrhage around the time of RPGN whereas the remaining case demonstrated pulmonary hemorrhage a few years later. Renal tissue specimens in 3 cases showed circumferential crescents and linear immunoglobulin G deposits along the glomerular capillary loops in glomeruli. Two autopsy specimens revealed vasculitis of the small arteries and arterioles of the kidney, and one of them showed similar vasculitic findings in both the gastrointestinal tract walls and the adipose tissues of the adrenal glands. Additionally, a case with pulmonary hemorrhage occurring after remission was associated with re-elevated MPO-ANCA levels but without anti-GBM Ab positivity. A gastric biopsy was unremarkable and non-contributory for the diagnosis, but this case showed vasculitic symptoms of peripheral neuritis and retinal hemorrhage. Taken together, all 4 cases demonstrated prior pulmonary fibrosis and dual positivity of MPO-ANCA as well as anti-GBM Abs at the time of RPGN, and were associated with either pulmonary hemorrhage or its occurrence thereafter.
Conclusion
Four cases that showed prior pulmonary fibrosis as well as subsequent RPGN and pulmonary hemorrhage were both MPO-ANCA- and anti-GBM Ab-positive at the time of RPGN. The glomeruli disclosed features compatible with anti-GBM Ab disease, but the clinical and pathological vasculitic manifestations, including prior pulmonary fibrosis that might be an early manifestation of ANCA disease, suggested the occurrence of MPO-ANCA-associated vasculitis. Furthermore, 1 case subsequently showed repetitive pulmonary hemorrhage with re-elevated MPO-ANCA positivity but without anti-GBM Ab positivity, and this event was possibly due to MPO-ANCA-associated alveolar capillaritis. As anti-GBM Ab disease is generally thought not to manifest the clinical and pathological features of vasculitis excluding the kidney, MPO-ANCA might be a key factor regarding the occurrence of this dual positive disease.
Similar content being viewed by others
References
Goodpasture WE. The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci. 1991;158:863–70.
Rees AJ, Lookwood CM. Antiglomerular basement antibody-mediated nephritis. In: Schrier RW, Gottschalk CW, editors. Diseases of the kidney. Boston: Little, Brown; 1988. p. 2091–126.
Falk RJ, Hogan S, Carey TS, Jennette JC, The Glomerular Disease Collaborative Network. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med. 1990;113:656–63.
Geffriaud-Ricouard C, Noël LH, Chauveau D, Houhou S, Grünfeld JP, Lesarvre P. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol. 1993;39:125–36.
Jennette JC, Falk RJ. Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. Nephrol Dial Transpl. 1998;13(Suppl 1):16–20.
Bajema IM, Hagen EC, Heer E, van der Woude FJ, Bruijn JA. Colocalization of ANCA antigens and fibrinoid necrosis in ANCA-associated vasculitis. Kidney Int. 2001;60:2025–30.
Cohen-Tervaert JW, Limburg PC, Elema JD, Huitema MG, Horst G, The TH, et al. Detection of autoantibodies against myeloid lysozomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med. 1991;91:59–66.
Nakabayashi K. Nationwide survey of small vessel vasculitides for prevalence, prognosis, and quality of life in Japan. The 1998 annual report of the Research Committee of the Refractory Vasculitis Syndrome sponsored by Ministry of Health, Labour, and Welfare of Japan. In: Hashimoto H, editor. The study project for the refractory diseases. Tokyo: Ministry of Health, Labour, and Welfare of Japan; 1999. p. 38–48 (in Japanese).
Donaghy M, Rees AJ. Cigarette smoking and lung hemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet. 1983;321:1390–3.
Jennette JG. Nephrology forum; rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63:1164–77.
O’Donoghue DJ, Short CD, Brenchley PE, Lawler W, Ballardie FW. Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease. Clin Nephrol. 1989;32:251–5.
Jayne DRW, Marshall PD, Jones SJ, Lockwood M. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990;37:965–70.
Bosch X, Mirapeix E, Font J, Borrellas X, Rodriguez R, Lopez-Soto A, et al. Prognostic implication of anti-neutrophil cytoplasmic antoantibodies with myeloperoxidase specificity in anti-glomerular basement disease. Clin Nephrol. 1991;36:107–13.
Arimura Y, Minoshima S, Kamiya Y, Nakabayashi K, Kitamoto K, Nagasawa T. A case of Goodpasture’s syndrome associated with anti-myeloperoxidase antibodies. Intern Med. 1992;31:234–43.
Bonsib SM, Goelen JA, Kemp JD, Chandran P, Shadur C, Wilson L. Coexistent anti-neutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody associated disease: report of six cases. Mod Pathol. 1993;6:526–30.
Tamai O, Hori Y, Kouno K, Egami J, Oohara A, Matsuoka H, et al. A case of anti-glomerular basement membrane antibody (AGBMA) nephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA). Jpn J Nephrol. 1994;36:769–73. (in Japanese, abstract in English).
Kobayashi M, Saito M, Minoshima S, Arimura Y, Nagasawa T. A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement antibody (anti-GBM Ab). Jpn J Nephrol. 1995;37:207–11. (in Japanese, abstract in English).
Kalluri R, Meyers K, Mogyorosi A, Madaio MP, Nielson EG. Goodpasture syndrome involving overlap with Wegener’s granulomatosis and anti-glomerular basement membrane disease. J Am Soc Nephrol. 1997;8:1795–800.
Inoue A, Ino-oka N, Konishi K, Shindoh Y, Suzuki T, Ono Y. A case of Goodpasture’s syndrome with myeloperoxidase specific anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) during chronic interstitial pneumonia. J Jpn Respir Soc. 1997;35:1356–62.
Takeda T, Takeda T, Naiki Y, Yonekawa S, Sakaguchi M, Iwamoto I, et al. An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture’s syndrome onset of crescentic glomerulonephritis. Jpn J Nephrol. 1998;40:591–6. (in Japanese, abstract in English).
Inada Y, Tanaka Y, Saito K, Fujii K, Aso M, Nishino T, et al. A case of mixed connective tissue disease with microscopic polyarteritis nodosa associated with perinuclear-antineutrophil cytoplasmic antibody and anti-glomerular basement membrane. Jpn J Clin Immunol. 1999;22:342–7. (in Japanese, abstract in English).
Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66:1535–40.
Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Cohen-Tervaert JW. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCA in crescentic glomerulonephritis. Am J Kidney Dis. 2005;46:253–62.
Namba T, Hatanaka M, Takahashi A, Takeji M, Takehara K, Uzu T, et al. Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies. Jpn J Nephrol. 2008;50:64–8. (in Japanese, abstract in English).
Yamazaki C, Arai S, Tamura Y, Suzuki Y, Nakajima H, Kojima K, et al. A case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis. Jpn J Nephrol. 2009;51:490–5. (in Japanese, abstract in English).
Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol. 1997;8:376–85.
Serratrice J, Chiche L, Dussol B, Granel B, Daniel L, Jego-Desplat S, et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis. 2004;43:e26–30.
Vanhile Ph, Noel LH, Reumaux D, Fleury D, Lemaitre V, Gobert P. Late emergence of systemic vasculitis with anti-neutrophil cytoplasmic antibodies in a dialyzed patient with antiglomerular basement membrane glomerulonephritis. Clin Nephrol. 1990;33:257–8.
Peces R, Rodriguez M, Pobes A, Seco M. Sequential development of pulmonary hemorrhage with MPO-ANCA complicating anti-glomerular basement membrane antibody mediated glomerulonephritis. Am J Kidney Dis. 2000;35:954–7.
Nakabayashi K, Arimura Y, Yoshihara K, Fukuoka T, Karube M, Yamato T, et al. Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-center experience. Mod Rheumatol. 2009;19:420–6.
Arimura Y, Minoshima S, Tanaka U, Fujii A, Kobayashi M, Nakabayashi K, et al. Pulmonary manifestations in patients with myeloperoxidase anti-neutorophil-cytoplasmic antibody. Ryumachi. 1995;35:46–55. (in Japanese, abstract in English).
Nakabayashi K, Sumiishi A, Sano K, Fujioka Y, Yamada A, Karube M, et al. Tubulointerstitial nephritis without glomerular lesions in three patients with myeloperoxidase (MPO)-ANCA associated vasculitis. Clin Exp Nephrol. 2009;13:605–13.
Homma S, Matsushita H, Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology. 2004;9:190–6.
Shiraki A, Ando M, Shindo J, Abe T, Wakahara K, Makino Y, et al. Prevalence of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPO-ANCA) in patients with interstitial pneumonia. J Jpn Resp Soc. 2007;45:921–6. (in Japanese, abstract in English).
Wu M-J, Rajaram R, Shelp WD, Beirne GJ, Burkholder PM. Vasculitis in Goodpasture’s syndrome. Arch Pathol Lab Med. 1980;104:300–2.
Kondo N, Tateno M, Yamaguchi J, Yoshiki T, Itoh T Kawashima N, et al. Immunopathological studies of an autopsy case with Goodpasture’s syndrome and systemic necrotizing angiitis. Acta Pathol Jpn. 1986;36:595–604.
Acknowledgment
This work was supported in part by grants (2001–2007) from the Research Committee of Refractory Vasculitis Syndrome sponsored by the Ministry of Health, Labor, and Welfare of Japan.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nakabayashi, K., Fujioka, Y., Nagasawa, T. et al. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases. Clin Exp Nephrol 15, 226–234 (2011). https://doi.org/10.1007/s10157-010-0390-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-010-0390-0